Financial Statements — OTLY
Balance Sheet
(in billions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 |
|---|
| Cash & Equivalents | 0.06 | 0.10 | 0.25 | 0.08 | 0.30 |
| Inventory | 0.07 | 0.07 | 0.07 | 0.11 | 0.10 |
| Total Current Assets | 0.27 | 0.30 | 0.48 | 0.48 | 0.81 |
| Total Non-current Assets | 0.52 | 0.50 | 0.63 | 0.74 | 0.82 |
| Total Assets | 0.79 | 0.80 | 1.12 | 1.23 | 1.63 |
| Total Current Liabilities | 0.56 | 0.54 | 0.58 | 0.34 | 0.24 |
| Total Non-current Liabilities | 0.21 | 0.16 | 0.20 | 0.09 | 0.14 |
| Total Liabilities | 0.77 | 0.70 | 0.78 | 0.43 | 0.38 |
| Retained Earnings | (1.40) | (1.25) | (1.06) | (0.67) | (0.31) |
| Total Stockholder Equity | 0.02 | 0.11 | 0.34 | 0.79 | 1.25 |
Income Statement
(in millions USD) (except per-share rows)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 |
|---|
| Total Revenue | 862.46 | 823.67 | 783.35 | 722.24 | 643.19 |
| Cost of Revenue* | 585.40 | 587.17 | 631.27 | 642.21 | 488.18 |
| Gross Profit | 277.06 | 236.49 | 152.08 | 80.03 | 155.01 |
| Research & Development | 18.57 | 30.14 | 21.05 | 22.26 | 16.77 |
| Selling, General & Admin | 320.64 | 324.72 | 373.40 | 412.80 | 353.93 |
| Total Operating Expenses* | 344.79 | 422.64 | 609.10 | 476.01 | 368.76 |
| Operating Income | (67.73) | (186.15) | (457.01) | (395.98) | (213.74) |
| Pretax Income | (144.92) | (198.57) | (408.16) | (397.39) | (215.05) |
| Tax Provision | 8.20 | 3.70 | 8.90 | (4.83) | (2.65) |
| Net Income | (153.11) | (202.27) | (417.06) | -- | -- |
| Basic EPS | (0.25) | (0.34) | (0.70) | (0.66) | -- |
| Diluted EPS | (0.25) | (0.34) | (0.70) | (0.66) | -- |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 |
|---|
| Operating Cash Flow | (23.72) | (114.43) | (165.63) | (268.95) | (213.83) |
| Investing Cash Flow | (15.54) | (9.25) | (26.70) | 34.79 | (544.33) |
| Financing Cash Flow | 1.18 | (27.29) | 355.00 | 35.92 | 955.80 |
